- JP-listed companies
- Kringle Pharma,Inc.
- Balance sheet
Kringle Pharma,Inc.JP:4884
Market cap
¥2.6B
P/E ratio
-2.3x
| 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| Cash and cash equivalents | - | 505 | 166 | 2,103 | 2,138 | 2,756 | 2,136 | 2,313 | 1,619 |
| Inventories | - | - | - | - | 88 | - | - | - | - |
| Total current assets | - | 566 | 251 | 2,349 | 2,635 | 3,208 | 2,618 | 2,756 | 2,055 |
| Total non-current assets | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 24 |
| Total assets | - | 567 | 252 | 2,350 | 2,636 | 3,209 | 2,619 | 2,757 | 2,079 |
| Total current liabilities | - | 46 | 33 | 159 | 127 | 163 | 209 | 128 | 109 |
| Total non-current liabilities | - | 2 | 2 | 2 | 2 | 257 | 388 | 521 | 661 |
| Total liabilities | - | 48 | 35 | 162 | 129 | 420 | 597 | 649 | 770 |
| Common stock and paid-in capital | - | 864 | 864 | 2,954 | 2,807 | 3,118 | 3,193 | 2,847 | 2,952 |
| Retained earnings | - | -346 | -648 | -765 | -301 | -332 | -1,186 | -756 | -1,673 |
| Stockholders' equity | 383 | 518 | 216 | 2,189 | 2,506 | 2,789 | 2,022 | 2,108 | 1,309 |